» Articles » PMID: 8506958

Accelerated Atherosclerosis in Hyperlipidemic C57BL/6 Mice Treated with Cyclosporin A

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1993 Jun 1
PMID 8506958
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We and others have demonstrated that T lymphocytes are prominent components of atherosclerotic lesions. We hypothesized that if T cells were necessary for the development of atherosclerosis it would be possible to demonstrate its prevention or retardation in T-cell-suppressed mice. To test this hypothesis, CyA, a potent suppressor of T-cell activation, was used to treat C57BL/6 mice undergoing lipid hyperalimentation. Mice receiving normal mouse chow were completely free of atherosclerotic lesions. In mice receiving the atherogenic diet plus control oil injections, lesions of the aorta and coronary arteries were observed at 135 days and increased progressively in area until 310 days. Somewhat surprisingly, mice given the atherogenic diet plus CyA injections displayed even larger lesions at all three observed time intervals. Although CyA did suppress T-cell reactivity sufficiently to obtain the expected prolongation of skin allografts, it did not suppress the development or progression of atherosclerotic lesions.

Citing Articles

Nutritional and potential health benefits of chufa oil, olive oil, and anhydrous milk fat against gallstone disease in a C57BL/6N mouse model.

Zommara M, Swelam S, Raya-Alvarez E, Imaizumi K, Elmahdy A, Alkhudhayri D Front Nutr. 2024; 11:1445484.

PMID: 39391681 PMC: 11464469. DOI: 10.3389/fnut.2024.1445484.


Propolis Reduces Inflammation and Dyslipidemia Caused by High-Cholesterol Diet in Mice by Lowering ADAM10/17 Activities.

Yigit E, Deger O, Korkmaz K, Huner Yigit M, Uydu H, Mercantepe T Nutrients. 2024; 16(12).

PMID: 38931216 PMC: 11206409. DOI: 10.3390/nu16121861.


Sequential transplantation of the liver-kidney-heart from different donors: a case report.

Wang L, Zhang Y, Yu H, Song J, Wang Y Eur Heart J Case Rep. 2023; 7(10):ytad472.

PMID: 37854104 PMC: 10580372. DOI: 10.1093/ehjcr/ytad472.


Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A.

Voloshyna I, Teboul I, Kasselman L, Salama M, Carsons S, DeLeon J Inflamm Res. 2019; 68(9):787-799.

PMID: 31227843 DOI: 10.1007/s00011-019-01262-8.


Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.

Xia M, Chen D, Endresz V, Lantos I, Szabo A, Kakkar V PLoS One. 2015; 10(4):e0123393.

PMID: 25830298 PMC: 4382319. DOI: 10.1371/journal.pone.0123393.


References
1.
de Groen P . Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc. 1988; 63(10):1012-21. DOI: 10.1016/s0025-6196(12)64916-7. View

2.
EVANS G . Hypomagnesaemia, hypoalbuminaemia and plasma lipid changes in rats following the oral administration of ciclosporin. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1988; 89(2):375-6. DOI: 10.1016/0742-8413(88)90240-x. View

3.
Stamler J, Vaughan D, Rudd M, MUDGE G, Kirshenbaum J, Young P . Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol. 1988; 62(17):1268-72. DOI: 10.1016/0002-9149(88)90272-x. View

4.
Sakaguchi S, Sakaguchi N . Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol. 1989; 142(2):471-80. View

5.
Lustig S, Stern N, Golub M, Eggena P, Barrett J, Lee D . Experimental cyclosporin hypertension: characterization of the rat model. Transplant Proc. 1989; 21(1 Pt 1):950-1. View